However, a recent study, in melanoma cells, has demonstrated the involvement of p27 (increase of expression) rather than cyclin D1 in G1 cell cycle arrest induced by tunicamycin [62] and another study, in human breast cancer cells, showed that knockdown of PERK, results in cell cycle arrest in G2/M phase [63]. The gene discussed is CDKN1B; the disease is melanoma.